Key Financial Results (Consolidated)
Quarterly Performance (Q2 FY2027)
- Revenue from operations: ₹8,633.74 million (vs. ₹4,804.52 million in Q2 FY2026)
- Other income: ₹205.86 million (vs. ₹199.26 million in Q2 FY2026)
- Total income: ₹8,839.60 million (vs. ₹5,003.78 million in Q2 FY2026)
- Total expenses: ₹7,939.65 million (vs. ₹4,947.96 million in Q2 FY2026)
- Profit before tax: ₹899.95 million (vs. ₹55.52 million in Q2 FY2026)
- Total tax expense: ₹85.51 million (vs. tax reversal of ₹4.41 million in Q2 FY2026)
- Profit for the period: ₹814.44 million (vs. ₹59.93 million in Q2 FY2026)
- Earnings per share (basic and diluted): ₹6.48 (vs. ₹0.47 in Q2 FY2026)
Half-Yearly Performance (H1 FY2027)
- Revenue from operations: ₹15,724.15 million (vs. ₹9,346.55 million in H1 FY2026)
- Other income: ₹267.33 million (vs. ₹239.75 million in H1 FY2026)
- Total income: ₹15,991.48 million (vs. ₹9,586.30 million in H1 FY2026)
- Total expenses: ₹14,700.33 million (vs. ₹9,405.28 million in H1 FY2026)
- Profit before tax: ₹1,291.15 million (vs. ₹180.72 million in H1 FY2026)
- Total tax expense: ₹172.92 million (vs. ₹25.46 million in H1 FY2026)
- Profit for the period: ₹1,118.23 million (vs. ₹155.26 million in H1 FY2026)
- Earnings per share (basic and diluted): ₹8.89 (vs. ₹1.23 in H1 FY2026)
Key Financial Results (Standalone)
Quarterly Performance (Q2 FY2027)
- Revenue from operations: ₹8,526.65 million
- Profit for the period: ₹804.75 million
- Earnings per share (basic and diluted): ₹6.39
Half-Yearly Performance (H1 FY2027)
- Revenue from operations: ₹15,509.61 million
- Profit for the period: ₹1,092.58 million
- Earnings per share (basic and diluted): ₹8.68
Financial Position (Consolidated as of September 30, 2026)
- Total assets: ₹25,792.40 million (vs. ₹23,557.74 million as of March 31, 2026)
- Total equity: ₹12,706.35 million (vs. ₹11,575.44 million as of March 31, 2026)
- Total liabilities: ₹13,086.05 million (vs. ₹11,982.30 million as of March 31, 2026)
- Inventories: ₹3,920.48 million (vs. ₹3,235.94 million as of March 31, 2026)
- Trade receivables: ₹6,019.78 million (vs. ₹4,386.28 million as of March 31, 2026)
- Borrowings (current + non-current): ₹8,103.27 million (vs. ₹8,001.85 million as of March 31, 2026)
Cash Flow Statements (Consolidated H1 FY2027)
- Net cash from operating activities: ₹282.73 million
- Net cash from investing activities: ₹83.24 million
- Net cash used in financing activities: ₹292.02 million
- Net increase in cash & cash equivalents: ₹62.15 million
Auditor's Review and Qualifications
BNPS and Associates LLP conducted a limited review of the financial results as required by Regulation 33 of SEBI LODR Regulations. Key qualifications include:
- Reliance on other auditors for 2 subsidiaries representing total assets of ₹584.58 million and total income of ₹139.42 million for H1 FY2027
- 4 subsidiaries with unaudited financial information certified by management, representing total assets of ₹214.62 million and total income of ₹224.08 million for H1 FY2027
- The Group's share of profit from one associate was ₹Nil for both quarter and half year ended September 30, 2026
Significant Notes to Financial Results
1. SGST Incentive Income: Revenue includes ₹47.88 million (H1) and ₹22.17 million (Q2) recognized under Punjab Industrial Incentive Scheme, subject to final verification
2. Exceptional Items: ₹0.30 million recognized related to balance insurance claim from December 2024 fire incident (fully settled)
3. Hyperinflation Accounting: Applied Ind AS 29 to Turkish subsidiaries, resulting in loss of ₹25.82 million (H1) and ₹12.72 million (Q2)
4. Segment Reporting: Single reportable segment - Chemical Business
5. Entities Included: Financial results include Bodal Chemicals Limited (parent), 6 subsidiaries, and 1 associate